Processing

Please wait...

Settings

Settings

Goto Application

1. US20100261797 - Polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide

Office
United States of America
Application Number 12742304
Application Date 12.11.2008
Publication Number 20100261797
Publication Date 14.10.2010
Grant Number 08742172
Grant Date 03.06.2014
Publication Kind B2
IPC
C07C 233/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
233Carboxylic acid amides
A01N 37/18
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
37Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
18containing the group -CO-N, e.g. carboxylic acid amides or imides; Thio-analogues thereof
Applicants Cacciaglia Roberto
Laboratorio Farmaceutico C.T. S.R.L.
Ferrari Massimo
Inventors Cacciaglia Roberto
Ferrari Massimo
Agents DLA Piper LLP (US)
Wang Stephanie X.
Priority Data 07120551 13.11.2007 EP
Title
(EN) Polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
Abstract
(EN)

Crystalline polymorphic forms of a compound of formula N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide are described. The two polymorphic forms, named polymorphic Form A and polymorphic Form B, can be used in the treatment of drug addiction and alcoholism and have very good stability. Methods for preparing the polymorphic forms are also described.


Related patent documents
BRPI0819370This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.